References
- Danjoux CE, Rider WD, Fitzpatrick PJ. The acute radiation syndrome. A memorial to William Michael Court–Brown. Clin. Radiol.30, 581–584 (1979).
- Feyer PC, Maranzano E, Molassiotis A, Roila F, Clark-Snow RA, Jordan K. Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support. Care Cancer19(Suppl. 1), S5–S14 (2011).
- Maranzano E, De Angelis V, Pergolizzi S et al. A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother. Oncol.94(1), 36–41 (2010).
- The Italian Group for Antiemetic Research in Radiotherapy. Radiation-induced emesis: a prospective observational multicenter Italian trial. Int. J. Radiat. Oncol. Biol. Phys.44(3), 619–625 (1999).
- Enblom A, Bergius AB, Steineck G, Hammar M, Borjeson S. One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support. Care Cancer17(1), 23–32 (2009).
- Maranzano E. Radiation-induced emesis: a problem with many open questions. Tumori.87(4), 213–218 (2001).
- Horiot J. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int. J. Radiat. Oncol. Biol. Phys.60(4), 1018–1025 (2004).
- Roila F, Herrstedt J, Gralla RJ, Tonato M. Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conference. Support. Care Cancer19(Suppl. 1), S63–S65 (2011).
- Feyer PC, Maranzano E, Molassiotis A et al. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Support. Care Cancer13(2), 122–128 (2005).
- Wong RKS, Paul N, King K et al. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomised trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J. Clin. Oncol.24(21), 3458–3464 (2006).
- Kris MG, Hesketh PJ, Somerfield MR et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J. Clin. Oncol.24(18), 2932–2947 (2006).
- Gralla RJ, Osoba D, Kris MG et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J. Clin. Oncol.17(9), 2971–2994 (1999).
- Gralla RJ, Roila F, Tonato M. The 2004 Perugia antiemetic consensus guideline process: methods, procedures, and participants. Support. Care Cancer13(2), 77–79 (2005).
- Feyer P. The Importance of simple, easy-to-follow antiemetic guidelines. Acta Oncologica.43(Suppl. 15), 5–8 (2004).
- Feyer P, Seegenschmiedt MH. Antiemetic patterns of care for radiotherapy induced nausea and vomiting. ECCO12, 929 (2003).
- Goldsmith B. Antiemetic patterns of care for radiotherapy induced nausea and vomiting. Am. Soc. Clin. Oncol.22, 740 (2003).
- Kirkbride P, Bezjak A, Pater J et al. Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group Phase III study. J. Clin. Oncol.18(9), 1960–1966 (2000).
- Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA282(15), 1458–1465 (1999).
- Yamamoto K, Takeda N, Yamatodani A. Establishment of an animal model for radiation-induced vomiting in rats using pica. J. Radiat. Res.43, 135–141 (2002).
- Scarantino CW, Ornitz RD, Hoffman LG, Anderson RF. On the mechanism of radiation-induced emesis: the role of serotonin. Int. J. Radiat. Oncol. Biol. Phys.30(4), 825–830 (1994).
- Salvo N, Doble B, Kahn L et al. Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/j.ijrobp.2010.08.060 (2010) (Epub ahead of print).
- Olver I, Molassiotis A, Aapro M, Herrstedt J, Grunberg S, Morrow G. Antiemetic research: future directions. Support. Care Cancer19(Suppl. 1), S49–S55 (2011).
Website
- National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Antiemesis V1 (2012). www.nccn.org/clinical.asp